Title
Guidelines for CGMP Clearance of Foreign Drug Makers
Law
Fda Circular No. 2014-016
Decision Date
May 30, 2014
FDA Circular No. 2014-016 establishes guidelines for ensuring compliance with current Good Manufacturing Practices (cGMP) for foreign drug manufacturers, requiring them to obtain GMP clearance from the FDA prior to product registration and outlining the responsibilities of various FDA offices in the evaluation and inspection process.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.